n/a
Abstract Title:

NLRP3 inflammasome activation and lung fibrosis caused by airborne fine particulate matter.

Abstract Source:

Ecotoxicol Environ Saf. 2018 Nov 15 ;163:612-619. Epub 2018 Aug 6. PMID: 30092543

Abstract Author(s):

Runxiao Zheng, Lan Tao, Hui Jian, Yun Chang, Yan Cheng, Yanlin Feng, Haiyuan Zhang

Article Affiliation:

Runxiao Zheng

Abstract:

Airborne fine particulate matter (PM) has been known capable of causing lung inflammation and fibrosis, as a result of a series of chronic respiration diseases. Although NLRP3 inflammasome activation is essential for development of many chronic diseases, the relationship between PM-induced toxicological effect and NLRP3 inflammasome activation is rarely investigated. Since PMcontains a large population of nanosized materials and many types of nanomaterials can activate NLRP3 inflammasome, the NLRP3 inflammasome activation and lung fibrosis induced by PMwere investigated in the present study. PMwas found capable of causing weak cell death but potent IL-1β secretion in THP-1 cells, which was involved in NLRP3 inflammasome activation as evidenced by Z-YVAD-FMK inhibited IL-1β secretion and overexpressed ASC and NLRP3 protein in PMtreated cells. PMcould be internalized into cells through multiple endocytosis processes, such as phagocytosis and pinocytosis (macropinocytosis, clathrin- and caveolin-mediated endocytosis), and activate NLRP3 inflammasome through cathepsin B release, ROS production, and potassium efflux. After 21 days of exposure to PMthrough oropharyngeal aspiration, Balb/c mice showed increased IL-1β and TGF-β1 levels in the bronchoalveolar lavage fluid (BALF) of lung and significant collagen deposition around small airways of mice, suggesting potential lung inflammation and pulmonary fibrosis.

Study Type : In Vitro Study

Print Options


This website is for information purposes only. By providing the information contained herein we are not diagnosing, treating, curing, mitigating, or preventing any type of disease or medical condition. Before beginning any type of natural, integrative or conventional treatment regimen, it is advisable to seek the advice of a licensed healthcare professional.

© Copyright 2008-2024 GreenMedInfo.com, Journal Articles copyright of original owners, MeSH copyright NLM.